Matt Olszewski
Content/Blog Writer for Healthcare clients
- 5.00
- Rating
Boston, USA
Verve Gets FDA Go-Ahead for First In-Human Base Editing Study i…
0
10
AnaptysBio Touts Positive Top-Line Phase III Data for Pustular …
0
4
Amicus Gets FDA Approval for Rare Muscle Disorder Treatment
0
3
Appili Gets FDA Approval for Liquid, Oral Reformulation of Anti…
0
2
Gilead’s Magrolimab Again Placed on Partial Clinical Hold by FDA
0
7
Chimerix’s Drug Candidate Improves Brain Tumor Survival Rate
0
7
HIV and Increased Risk for Heart Attack
0
7
NIAID funds Post-Treatment Lyme Disease Syndrome research
0
18
Taking Statins to Reduce Cardiovascular Disease in T2 Diabetics
0
27
Endocarditis in Intravenous Drug Users: A Dangerous Infection
0
15